Ventilator pneumonia lawsuits stem from two distinct but related problems: defective respiratory devices that fail to function properly, and hospital-acquired pneumonia that develops when patients on mechanical ventilators receive inadequate care or monitoring. These lawsuits seek compensation for patients harmed by either faulty equipment or medical negligence that allowed dangerous infections to develop while on life support. In December 2024, Philips Respironics agreed to pay $1.1 billion to settle lawsuits involving defective CPAP, BiPAP, and ventilator machines, with approximately 680 sleep apnea device cases still pending in federal court. This settlement reflects the serious nature of these claims and the documented harm caused by equipment failures and hospital-acquired infections.
Ventilator pneumonia encompasses a broader category of litigation than device defects alone. Patients who develop ventilator-associated pneumonia (VAP)—a serious infection that develops in 9 to 27 percent of mechanically ventilated patients—may have grounds for medical malpractice claims if hospitals fail to follow infection prevention protocols. Individual settlements in these cases have reached as high as $2 million, with typical medical malpractice settlements averaging around $250,000 for hospital-acquired infection cases. Understanding the landscape of ventilator pneumonia litigation requires examining both the device manufacturers involved and the hospitals where inadequate care contributes to infections.
Table of Contents
- What Are Device Defect Ventilator Lawsuits?
- Understanding Ventilator-Associated Pneumonia and Medical Malpractice
- Recent FDA Recalls and Device Safety Actions
- Settlement Amounts and Compensation in Ventilator Pneumonia Cases
- Complications and Medical Risks Associated with Ventilator Use
- How Patients and Families Can Pursue Ventilator Pneumonia Claims
- Ongoing Litigation and Future Outlook
- Conclusion
What Are Device Defect Ventilator Lawsuits?
Device defect ventilator lawsuits target manufacturers like Philips Respironics and Smiths Medical for producing respiratory equipment that fails to meet safety standards or functions unreliably. The Philips Respironics litigation represents the largest settlement in this category. On August 4, 2024, the FDA issued a Class I recall of Philips BiPAP A30, A40, and V30 ventilators after documenting at least 8 deaths and 13 injuries linked to a critical “Ventilator Inoperative” alarm failure. This defect meant patients using these devices had no warning when the equipment stopped working, creating life-threatening situations where patients dependent on mechanical ventilation received no respiratory support. The Smiths Medical litigation addresses similar manufacturing defects in the paraPAC Plus P300 and P310 ventilators.
These devices experienced malfunctions that disrupted life-sustaining respiratory support, coupled with inadequate quality controls that allowed defective equipment to reach patients. Unlike settlements that have already been finalized, the Smiths Medical cases remain under active investigation, with ongoing examination of how manufacturing defects compromised patient safety. Patients injured by these devices can pursue claims based on product liability, failure to warn, and breach of warranty theories. What distinguishes device litigation from other ventilator cases is that it does not require proving hospital negligence. Instead, plaintiffs must demonstrate that the manufacturer knew or should have known about the defect, failed to adequately warn users, or did not recall the product in a timely manner. The FDA’s involvement and documented deaths or injuries substantially strengthen these claims.
Understanding Ventilator-Associated Pneumonia and Medical Malpractice
Ventilator-associated pneumonia (VAP) develops in hospitalized patients while they are on mechanical ventilators, typically after 48 hours of intubation. The infection occurs when bacteria colonize the lungs, often due to aspiration of contaminated oral secretions or inadequate infection control measures. Medical literature shows that 9 to 27 percent of all mechanically ventilated patients develop VAP, with mortality rates between 20 and 30 percent—making it a leading cause of hospital-acquired infections. VAP has been ranked as the 9th most common medical error in U.S. hospitals, highlighting both its prevalence and the preventable nature of many cases. Medical malpractice claims arise when hospitals or healthcare providers fail to implement evidence-based VAP prevention protocols.
These protocols include semi-recumbent positioning of patients, oral hygiene care, sedation management, and timely removal of ventilators when patients no longer need them. A Chicago case resulted in a $900,000 settlement for pneumonia misdiagnosis and failure to properly manage a ventilated patient, while another case settling for $2 million involved a patient death from acute hypoxemic respiratory failure complicated by ventilator-associated pneumonia and acute respiratory distress syndrome. These settlements demonstrate that courts recognize substantial damages when hospitals breach their duty to protect vulnerable, mechanically ventilated patients. An important limitation to understand is that not every case of VAP constitutes medical malpractice. Courts require evidence that the hospital’s actions (or failure to act) directly caused or substantially contributed to the pneumonia development. Simply developing VAP while hospitalized is not automatically grounds for a successful lawsuit.
Recent FDA Recalls and Device Safety Actions
The FDA’s August 2024 class I recall of Philips BiPAP and ventilator equipment represented a critical turning point in device safety oversight. A Class I recall is the most serious FDA classification, indicating a reasonable probability that use of the product will cause serious adverse health consequences or death. The specific defect—failure of the Ventilator Inoperative alarm—created a hidden hazard: patients and caregivers would not receive any warning that the device had stopped delivering life-sustaining respiratory support. This design flaw affected patients with sleep apnea, patients with chronic respiratory diseases, and others requiring supplemental ventilation.
Beyond the Philips recall, the regulatory landscape continues to scrutinize ventilator manufacturers. The Smiths Medical investigation remains ongoing, with the FDA and legal team examining manufacturing processes and quality control failures that allowed defective paraPAC Plus devices to reach the market. As of May 2025, Daubert hearings—the legal proceedings where courts evaluate expert testimony in the Philips litigation—are scheduled for May or June 2025, with jury trials expected to begin no earlier than late 2025. This extended timeline reflects the complexity of device defect cases and the need for thorough expert analysis.
Settlement Amounts and Compensation in Ventilator Pneumonia Cases
The Philips Respironics $1.1 billion settlement stands as the largest resolution in ventilator-related litigation, reflecting not only the number of claims but also the severity of potential injuries. With 680 lawsuits still pending in MDL 3014 (a multidistrict litigation consolidating similar cases), individual recovery amounts will depend on the specific injuries, duration of harm, and quality of evidence in each case. Some settlements may be substantially higher or lower than the average, depending on documented causation and severity.
Medical malpractice cases involving VAP show more variability in settlement amounts. The $2 million settlement for a fatal case involving acute respiratory distress syndrome and ventilator-associated pneumonia represents the high end, while the $900,000 settlement for misdiagnosis represents mid-range recovery. The approximate average of $250,000 for hospital-acquired infection malpractice cases provides a baseline, though cases involving permanent disability, extended hospitalization, or death typically recover substantially more. A critical tradeoff exists between pursuing settlement quickly versus waiting for trial: settlements offer certainty and faster compensation, while jury verdicts can exceed settlement offers but carry the risk of losing entirely.
Complications and Medical Risks Associated with Ventilator Use
Patients dependent on mechanical ventilators face multiple infection risks beyond pneumonia alone. The process of intubation itself—inserting a tube through the mouth or nose into the trachea—bypasses the body’s natural defenses against bacterial colonization. Prolonged intubation increases the risk of secondary infections, sinusitis, and tracheitis. Additionally, patients on ventilators often cannot cough or clear secretions effectively, allowing bacteria to pool in the lungs and progress to full infection.
The 20 to 30 percent mortality rate associated with VAP means that a substantial percentage of patients who develop this complication will die from it, even with treatment. This high mortality underscores why medical negligence in VAP prevention constitutes such serious harm. Warning signs that hospitals may not be following VAP prevention protocols include: failure to elevate the head of the bed, inadequate oral care, prolonged sedation preventing weaning from the ventilator, and delayed extubation when patients are ready to breathe independently. A limitation of VAP litigation is that patients must be able to prove the hospital’s specific failure caused or materially contributed to their infection—developing VAP while on a ventilator alone does not establish negligence.
How Patients and Families Can Pursue Ventilator Pneumonia Claims
Pursuing a ventilator pneumonia lawsuit begins with consulting with an attorney experienced in either product liability (for device defect cases) or medical malpractice (for hospital-acquired infection cases). For device defects, patients should gather documentation including the device model and serial number, FDA recall notices, medical records showing the device failure, and evidence of injuries. Many Philips Respironics claims have already been resolved through the settlement program, though some cases may still be within applicable claim periods.
For medical malpractice VAP cases, documentation should include hospital medical records detailing ventilator management, infection control protocols (or lack thereof), nursing notes, physician orders, and expert medical testimony establishing breach of the standard of care. An experienced medical malpractice attorney can connect you with medical experts who can review whether your hospital met evidence-based VAP prevention standards. Statute of limitations requirements vary by state but typically range from one to three years from injury discovery, making it important to consult an attorney promptly.
Ongoing Litigation and Future Outlook
The ventilator litigation landscape will continue evolving as Daubert hearings in the Philips MDL progress through 2025 and jury trials commence. The outcome of early trials will significantly influence settlement negotiations for the remaining 680 pending cases, potentially increasing or decreasing individual recovery amounts. Additionally, the ongoing Smiths Medical investigation may result in additional recalls, regulatory actions, or settlement demands as evidence accumulates regarding manufacturing defects.
The prevalence of VAP in hospitals—affecting millions of ventilated patients annually—ensures that medical malpractice litigation in this area will remain active. Hospital systems that fail to adopt or maintain evidence-based VAP prevention protocols face increasing legal exposure as juries demonstrate willingness to award substantial damages for preventable infections. The combination of documented medical errors (VAP as the 9th most common error) and available proven prevention methods strengthens future plaintiffs’ cases.
Conclusion
Ventilator pneumonia lawsuits represent one of the most important developments in medical device and hospital safety litigation. Device defect cases like the Philips Respironics $1.1 billion settlement hold manufacturers accountable for equipment failures that can result in death or serious injury. Simultaneously, medical malpractice lawsuits seek compensation when hospitals fail to prevent ventilator-associated pneumonia through negligent patient care.
Whether your claim involves a defective device or hospital-acquired infection, understanding the legal landscape—settlement amounts, ongoing litigation timelines, and required evidence—enables informed decision-making about pursuing compensation. If you or a family member has been harmed by a faulty ventilator, developed ventilator-associated pneumonia due to hospital negligence, or experienced serious complications related to respiratory device failure, contact an attorney with experience in medical device and hospital liability cases. Time limits apply to these claims, and evidence preservation becomes critical early in the litigation process. An experienced legal team can evaluate the specifics of your case, explain your options, and help you pursue appropriate compensation for your injuries and losses.